Denies any association with John Fikany and Jerry Capussi and categorically refutes the insinuations made on behalf of these individuals
Company requesting immediate retraction while reserving the right to seek relief
Remains focused on executing its business plan to develop cannabis-based medicines and products
GRANTS, N.M., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced refutation of allegations made public by Mr. Jerry Capussi and Mr. John Fikany. The Company remains focused on continued execution of its business plan and is awaiting full approval from the U.S. Drug Enforcement Administration (DEA).
Bright Green refutes the claims made by Mr. Capussi and Mr. Fikany, specifically:
Mr. Fikany has never been, nor offered the role, of Chief Executive Officer of Bright Green Corporation.
Bright Green has been and remains fully compliant in both its listing on the Nasdaq and its Securities and Exchange Commission (SEC) reporting before and following the listing. There have been no allegations of securities fraud.
Litigation between John Stockwell and/or the Stockwell family related to prior relationships with Mr. Capussi and Mr. Fikany are not applicable to Bright...
Petrojam is strongly dismissing as false a message circulating via WhatsApp and social media platforms warning of a fuel shortage. "The claim is false and unfounded," the state-owned oil refinery...